| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/03/1997 | CA2240492A1 Aminoguanidine for treating niddm |
| 07/03/1997 | CA2240396A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781546A1 A multi-layered film preparation |
| 07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
| 07/02/1997 | EP0781127A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 07/02/1997 | EP0781124A1 Active agent transport systems |
| 07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
| 07/01/1997 | US5643963 Aging resistance of skin by reducing wrinkles |
| 07/01/1997 | US5643962 Skin disorders |
| 07/01/1997 | US5643961 Method of using malic acid for treating wrinkles |
| 07/01/1997 | US5643953 Method of using 3-phenyllactic acid for treating wrinkles |
| 07/01/1997 | US5643952 Skin disorders |
| 07/01/1997 | US5643944 Administering arginine, sodium nitroprusside, nitroglycerine and idosorbide mono or dinitrate mixture to stimulate ovulation |
| 07/01/1997 | US5643921 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
| 07/01/1997 | US5643915 Antiinflammatory agents |
| 07/01/1997 | US5643875 Proteins and endotoxins |
| 07/01/1997 | US5643874 Pharmaceutical composition comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643720 Method of inhibiting transcription utilizing nuclear receptors |
| 07/01/1997 | US5643623 Health food product and its uses |
| 07/01/1997 | US5643586 Skin disorders and antiaging agents |
| 07/01/1997 | US5643556 Stimulation of tanning by DNA fragments or single-stranded DNA |
| 06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022359A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation |
| 06/26/1997 | WO1997022354A2 Use of a medicament and use of mixture of substances to produce a medicament |
| 06/26/1997 | WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor. |
| 06/26/1997 | WO1997022339A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 06/26/1997 | WO1997022333A1 Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles |
| 06/26/1997 | WO1997022251A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | WO1997013845A3 Phosphopantetheinyl transferases and uses thereof |
| 06/26/1997 | DE19549232A1 Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum zur Herstellung eines pharmazeutischen Präparates zur verstärkten Mobilisierung hämatopoetischer Stammzellen Use of G-CSF in combination with a chemotherapeutic agent for the preparation of a pharmaceutical composition for enhanced mobilization of hematopoietic stem cells |
| 06/26/1997 | CA2241004A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 06/26/1997 | CA2240729A1 Use of a medicament and use of mixture of substances to produce a medicament |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/25/1997 | EP0779820A1 Bioadhesive-wound healing composition |
| 06/25/1997 | EP0779817A1 Enteral vaccine for vaginal infections |
| 06/25/1997 | EP0779813A1 Phosphonates and parathyroid hormone for osteoporosis |
| 06/25/1997 | EP0779812A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 06/25/1997 | EP0779810A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | CN1152873A New pharmaceutical preparationf or pain management |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/25/1997 | CN1152468A Slow releasing composition |
| 06/24/1997 | US5641814 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 06/24/1997 | US5641803 Injecting regulated dosages over a shorter time period causes less myelosuppression and hematologic toxicity |
| 06/24/1997 | US5641744 Treatment of diabetes mellitus |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641512 Shell contains xanthine derivative |
| 06/19/1997 | WO1997021993A2 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | WO1997021820A2 A novel protein kinase required for ras signal transduction |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021731A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | WO1997021685A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/19/1997 | WO1997021445A1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 06/19/1997 | WO1997021434A1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| 06/19/1997 | WO1997021430A2 Surface-stabilised pharmaceutical preparation for application on the skin |
| 06/19/1997 | WO1997016549A3 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 06/19/1997 | CA2509505A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | CA2240165A1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| 06/19/1997 | CA2240024A1 Nuclear receptor ligands and ligand binding domains |
| 06/19/1997 | CA2239293A1 Assay for and uses of peptide hormone receptor ligands |
| 06/18/1997 | EP0778848A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 06/18/1997 | EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity |
| 06/18/1997 | EP0778770A1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer |
| 06/18/1997 | EP0778768A1 Formulations and methods for providing prolonged local anesthesia |
| 06/18/1997 | CN1151893A Combination antiemetic therapy using NK-1 receptor antagonists |
| 06/17/1997 | US5639887 MDR reversal agents |
| 06/17/1997 | US5639858 Polypeptide |
| 06/17/1997 | US5639792 No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption |
| 06/17/1997 | US5639758 Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 06/17/1997 | US5639738 Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/12/1997 | WO1997021103A1 Treatment and diagnosis of infections due to helicobacter pylori |
| 06/12/1997 | WO1997021100A1 Hiv protease inhibitors |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020572A1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 06/12/1997 | WO1997020561A1 Composition for treating pain |
| 06/12/1997 | WO1997020556A1 Method for treating pain |
| 06/12/1997 | WO1997020553A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 06/12/1997 | WO1997020552A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors |
| 06/12/1997 | WO1997004668A3 Two-stage preparation |
| 06/12/1997 | DE19546024A1 Flächenstabilisierte pharmazeutische Zubereitung zur Anwendung auf der Haut Surface stabilized pharmaceutical preparation for application to the skin |
| 06/12/1997 | DE19545892A1 Preventing resistance development in cytostatic cancer therapy |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239732A1 Method for treating pain |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238815A1 Composition for treating pain |
| 06/12/1997 | CA2238337A1 Hiv protease inhibitors |
| 06/11/1997 | EP0778023A1 Neuroprotective agents |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |